The Intersection of Antitrust Law and Intellectual Property Rights Under the New Obama Administration

This article is part of a Chronicle. See more from this Chronicle Christopher R. Leslie, Jan 20, 2009 Political predictions are fraught with peril. Correctly foretelling what policies a new president will pursue and whether his efforts will prove successful is particularly difficult for matters that were not discussed extensively in stump speeches or the […]

From Walker Process to In re DDAVP: Should Direct Purchasers Have Antitrust Standing in Walker Process Claims?

This article is part of a Chronicle. See more from this Chronicle Aidan Synnott, Nov 29, 2008 In In re: DDAVP Direct Purchaser Antitrust Litigation, decided in 2006, the district court held that direct purchasers of a product from a monopolist which secured its monopoly by fraud on the Patent Office do not have standing […]

The Pharmaceutical Inquiry: Anything to Report?

This article is part of a Chronicle. See more from this Chronicle Sean-Paul Brankin, Nov 12, 2008 One reaction to the pharmaceuticals sector inquiry, particularly from the originator side of the industry, has been to question the need for the investigation. What is certain is that the Commission has set itself a challenging task. It […]

The 2008 EC Sector Inquiry Regarding Pharmaceuticals: What Does It Mean from a Research-Based Company Perspective?

This article is part of a Chronicle. See more from this Chronicle Kent Bernard, Nov 12, 2008 A sector inquiry is never pleasant for the sector involved. It is much like going to the dentist for a checkup. The best possible result is that after all is said and done, nothing was wrong and life […]

Standards and Market Power

This article is part of a Chronicle. See more from this Chronicle Nicholas Banasevic, Cecilio Madero, May 16, 2008 Standards play an increasingly significant role in the modern economy, in particular in the high-tech sector. They ensure that products in an increasingly inter-connected world can work together properly, and therefore allow companies to concentrate on […]

The Importance of Antitrust in Standard Setting

This article is part of a Chronicle. See more from this Chronicle Mark Nelson, May 12, 2008 Ensuring the interoperability of products can be critical to the success of many industries, in particular to encourage the rapid uptake of new technologies. To achieve such interoperability and the efficiencies that come with it, industries often use […]

Harnessing SDO Innovation to Reduce Holdup, Uncertainty, and Inefficiency

This article is part of a Chronicle. See more from this Chronicle David Meyer, May 12, 2008 Collaboratively set standards are an important part of the global economy. As the U.S. Department of Justice (the “Department”) explained in last year’s “IP2 Report,” issued jointly with the U.S. Federal Trade Commission, collaboratively set standards are generally […]

The EC Sector Inquiry Regarding Pharmaceuticals: Some Thoughts from a U.S. Perspective

This article is part of a Chronicle. See more from this Chronicle Kent Bernard, Feb 06, 2008 On January 16, 2008, the European Commission launched a sector inquiry by staging dawn raids on a number of pharmaceutical companies. When a major competition authority such as the Commission launches an “inquiry” into a sector of the […]

The Logic and Limits of Ex Ante Competition in a Standard-Setting Environment

Damien Geradin, Anne Layne-Farrar, Apr 19, 2007 Some scholars have questioned the process by which cooperative standards are typically set, worrying about the potential for anticompetitive market power to come hand in hand with pro-competitive interoperability. To combat the perceived problems of ex post opportunism, the suggested solutions have focused on promoting procedures to facilitate […]

1 5 6 7